Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytes

Neurological Research

Volumn 19, Issue 2, 1997, Pages 145-152

  Merchant, Randall E ^a,b   Baldwin, Nevan G ^b   Rice, Charles D ^a   Bear, Harry D ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Neurosurgery   (United States)

^c Box 980011   (United States)

Author keywords

adoptive immunotherapy; bryostatin 1; Glioma; signal transduction

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GLIOMA; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RAT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0030892681     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1997.11740788     Document Type: Article

References (11)

1. Rosenberg SA. The immunotherapy and gene therapy of cancer. J Clin Oncol 1992; 10: 180-199
2. 8+ murine T cells from tumor-draining lymph nodes with phorbol dibutyrate plus calcium ionophore. J Immunother 1992; 12: 32-40
3. Kraft AS, Smith JB, Berkow RL. Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester induced differentiation of human promyelocytic progenitor cells HL-60. Proc Natl Acad Sci USA 1986; 83: 1334-1338
4. Schuchter LM, Esa AH, May WS, et al. Successful treatment of murine melanoma with bryostatin-1. Cancer Res 1991; 51: 682-687
5. Hornung RL, Pearson JW, Backwith M, et al. Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines. In vitro versus in vivo activity. Cancer Res 1992; 52: 101-107
6. Tuttle TM, Inge TH, Wirt CP, et al. Bryostatin 1 activates T cells which have antitumor activity. J Immunother 1992; 12: 75-81
7. Tuttle TM, Inge TH, Bethke KP, et al. Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1. Cancer Res 1992; 52: 548-553
8. Tuttle TM, McCrady CM, Inge TH, et al. Gamma-interferon plays a key role in T-cell-induced tumor regression. Cancer Res 1993; 53: 833-839
9. Baldwin NG, Rice CD, Tuttle TM, et al. Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo trafficking of glioma-sensitized lymphocytes. J Neuro Oncol 1997; 32: 19-28
10. Rice CD, Baldwin NG, Biron RT, et al. Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes. J Neuro Oncol 1997; 32: 29-38
11. Rice CD, Merchant RE. Murine recombinant interleukin-1β inhibits the growth and progression of malignant glioma in the rat. J Neuro-Oncol 1992; 13: 43-55